Breast cancers lacking both estrogen and progesterone receptors (ER and PR), with simultaneous absence of human epidermal growth factor 2 receptor (HER2) are defined as triple-negative breast cancers (TNBCs). The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.